134 related articles for article (PubMed ID: 30903664)
21. Visualizing Pericyte Mimicry of Angiotropic Melanoma by Direct Labeling of the Angioarchitecture.
Prakash R; Thareja NS; Carmichael TS; Barnhill RL; Lugassy C; Bentolila LA
Methods Mol Biol; 2021; 2235():1-12. PubMed ID: 33576966
[TBL] [Abstract][Full Text] [Related]
22. Monitoring Angiotropic Extravascular Migratory Metastasis In Vitro.
Lugassy C; Kleinman HK; Barnhill RL
Methods Mol Biol; 2023; 2572():91-100. PubMed ID: 36161410
[TBL] [Abstract][Full Text] [Related]
23. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.
Monteagudo C; Martin JM; Jorda E; Llombart-Bosch A
J Clin Pathol; 2007 Jun; 60(6):596-9. PubMed ID: 16522748
[TBL] [Abstract][Full Text] [Related]
24. CD31 and CD34 expression as immunohistochemical markers of endothelial transdifferentiation in human cutaneous melanoma.
Pisacane AM; Picciotto F; Risio M
Cell Oncol; 2007; 29(1):59-66. PubMed ID: 17429142
[TBL] [Abstract][Full Text] [Related]
25. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.
Massi D; Franchi A; Paglierani M; Ketabchi S; Borgognoni L; Reali UM; Santucci M
Hum Pathol; 2004 Apr; 35(4):496-502. PubMed ID: 15116332
[TBL] [Abstract][Full Text] [Related]
26. Conspicuous angiotropism of malignant melanoma involving the brain: implications for extravascular migratory metastasis.
Barnhill RL; Benson PJ; Lugassy C
Am J Dermatopathol; 2009 Apr; 31(2):205-8. PubMed ID: 19318812
[TBL] [Abstract][Full Text] [Related]
27. Satellite in transit metastases in rapidly fatal conjunctival melanoma: implications for angiotropism and extravascular migratory metastasis (description of a murine model for conjunctival melanoma).
Barnhill RL; Lemaitre S; Lévy-Gabrielle C; Rodrigues M; Desjardins L; Dendale R; Vincent-Salomon A; Roman-Roman S; Lugassy C; Cassoux N
Pathology; 2016 Feb; 48(2):166-76. PubMed ID: 27020389
[TBL] [Abstract][Full Text] [Related]
28. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.
Sahni D; Robson A; Orchard G; Szydlo R; Evans AV; Russell-Jones R
J Clin Pathol; 2005 Jul; 58(7):715-21. PubMed ID: 15976338
[TBL] [Abstract][Full Text] [Related]
29. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
[TBL] [Abstract][Full Text] [Related]
30. Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma.
Wilmott J; Haydu L; Bagot M; Zhang Y; Jakrot V; McCarthy S; Lugassy C; Thompson J; Scolyer R; Barnhill R
Histopathology; 2012 Nov; 61(5):889-98. PubMed ID: 22716270
[TBL] [Abstract][Full Text] [Related]
31. Extravascular migratory metastasis in gynaecological carcinosarcoma.
Dyke JM; Crook ML; Platten M; Stewart CJ
Histopathology; 2014 Sep; 65(3):363-70. PubMed ID: 24734932
[TBL] [Abstract][Full Text] [Related]
32. Atypical spitzoid melanocytic neoplasms with angiotropism: a potential mechanism of locoregional involvement.
Barnhill RL; Kutzner H; Schmidt B; Ali L; Bagot M; Janin A; Lugassy C
Am J Dermatopathol; 2011 May; 33(3):236-43. PubMed ID: 21389834
[TBL] [Abstract][Full Text] [Related]
33. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
[TBL] [Abstract][Full Text] [Related]
34. Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma.
Xu X; Gimotty PA; Guerry D; Karakousis G; Elder DE
Methods Mol Biol; 2014; 1102():275-86. PubMed ID: 24258984
[TBL] [Abstract][Full Text] [Related]
35. Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis.
Doeden K; Ma Z; Narasimhan B; Swetter SM; Detmar M; Dadras SS
J Cutan Pathol; 2009 Jul; 36(7):772-80. PubMed ID: 19032379
[TBL] [Abstract][Full Text] [Related]
36. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
37. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.
Niakosari F; Kahn HJ; Marks A; From L
Arch Dermatol; 2005 Apr; 141(4):440-4. PubMed ID: 15837861
[TBL] [Abstract][Full Text] [Related]
38. Angiotropic melanoma and extravascular migratory metastasis: a review.
Lugassy C; Barnhill RL
Adv Anat Pathol; 2007 May; 14(3):195-201. PubMed ID: 17452816
[TBL] [Abstract][Full Text] [Related]
39. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
40. Angiotropism of human prostate cancer cells: implications for extravascular migratory metastasis.
Lugassy C; Vernon SE; Warner JW; Le CQ; Manyak M; Patierno SR; Barnhill RL
BJU Int; 2005 May; 95(7):1099-103. PubMed ID: 15839940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
